Cyanotech (NASDAQ:CYAN) released its quarterly earnings results on Tuesday, February 6th. The biotechnology company reported $0.19 earnings per share for the quarter, Bloomberg Earnings reports. Cyanotech had a net margin of 5.44% and a return on equity of 10.23%. The business had revenue of $9.15 million during the quarter.
Shares of Cyanotech (NASDAQ CYAN) remained flat at $$4.80 on Thursday. The company’s stock had a trading volume of 13,900 shares, compared to its average volume of 13,187. The company has a quick ratio of 0.85, a current ratio of 2.44 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $27.61, a P/E ratio of 15.48 and a beta of 0.99. Cyanotech has a 52-week low of $3.25 and a 52-week high of $5.78.
Separately, ValuEngine cut Cyanotech from a “hold” rating to a “sell” rating in a research note on Friday, November 10th.
WARNING: “Cyanotech (NASDAQ:CYAN) Issues Earnings Results” was published by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://weekherald.com/2018/02/15/cyanotech-cyan-releases-quarterly-earnings-results.html.
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.